Cheap, flexible biosensor detects HIV, E-coli, Staph aureas

Florida Atlantic, Stanford, and Harvard  researchers have developed a thin, lightweight, flexible “paper microchip” biosensing platform to detect and determine treatment for HIV, E-coli, Staphylococcus aureas and other bacteria. They have also created an app that could remotely detect bacteria and disease in the blood using mobile phone images.

Current paper and flexible material-based platforms cost more and take longer.  The researchers claim that the new platforms are uniquely able to isolate and detect multiple biotargets selectively, sensitively, and repeatedly from diverse biological mediums using antibodies.

WEARABLE TECH + DIGITAL HEALTH NYC 2015 – JUNE 30 @ NEW YORK ACADEMY OF SCIENCES.  REGISTER HERE.